Cargando…

Analysis of pO(2) in Malignant Ascites of Patients with Peritoneal Dissemination of Gastric Cancer

OBJECTIVE: Oxygen is one of the most important environmental factors for tumor development. In this study, we examined pO(2) in malignant ascites in patients with peritoneal carcinomatosis. METHODS: In 21 patients with peritoneal dissemination of gastric cancer, ascitic fluid was collected and its p...

Descripción completa

Detalles Bibliográficos
Autores principales: Emoto, Shigenobu, Kitayama, Joji, Yamaguchi, Hironori, Ishigami, Hironori, Kaisaki, Shoichi, Nagawa, Hirokazu
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988845/
https://www.ncbi.nlm.nih.gov/pubmed/21103196
http://dx.doi.org/10.1159/000321262
_version_ 1782192293317443584
author Emoto, Shigenobu
Kitayama, Joji
Yamaguchi, Hironori
Ishigami, Hironori
Kaisaki, Shoichi
Nagawa, Hirokazu
author_facet Emoto, Shigenobu
Kitayama, Joji
Yamaguchi, Hironori
Ishigami, Hironori
Kaisaki, Shoichi
Nagawa, Hirokazu
author_sort Emoto, Shigenobu
collection PubMed
description OBJECTIVE: Oxygen is one of the most important environmental factors for tumor development. In this study, we examined pO(2) in malignant ascites in patients with peritoneal carcinomatosis. METHODS: In 21 patients with peritoneal dissemination of gastric cancer, ascitic fluid was collected and its pH, pCO(2) and pO(2) were determined using a blood gas analyzer. RESULTS: In 21 patients, pH of malignant ascites was significantly lower than that of arterial blood (7.39 ± 0.07, 7.44 ± 0.02, p < 0.05). Accordingly, pCO(2) tended to be higher in ascites than in arterial blood. Unexpectedly, pO(2) in malignant ascites showed relatively high values (90.4 ± 27.72 mm Hg), which were mostly the same as those of arterial blood (97.09 ± 10.33 mm Hg, p = 0.858). Even in 19 patients whose samples were collected at bedside in room air, pO(2) of malignant ascites was 85.94 ± 23.94 mm Hg, which was patently higher than that in venous blood or in solid tumor tissues. CONCLUSION: Since the oxygen level critically affects the sensitivity of tumor cells to chemotherapeutic agents through metabolic transformation, the oxygenic condition in the peritoneal cavity may be beneficial for the progression of peritoneal metastasis, and also clinically important in considering the efficacy of chemotherapy.
format Text
id pubmed-2988845
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-29888452010-11-22 Analysis of pO(2) in Malignant Ascites of Patients with Peritoneal Dissemination of Gastric Cancer Emoto, Shigenobu Kitayama, Joji Yamaguchi, Hironori Ishigami, Hironori Kaisaki, Shoichi Nagawa, Hirokazu Case Rep Oncol Published: October 2010 OBJECTIVE: Oxygen is one of the most important environmental factors for tumor development. In this study, we examined pO(2) in malignant ascites in patients with peritoneal carcinomatosis. METHODS: In 21 patients with peritoneal dissemination of gastric cancer, ascitic fluid was collected and its pH, pCO(2) and pO(2) were determined using a blood gas analyzer. RESULTS: In 21 patients, pH of malignant ascites was significantly lower than that of arterial blood (7.39 ± 0.07, 7.44 ± 0.02, p < 0.05). Accordingly, pCO(2) tended to be higher in ascites than in arterial blood. Unexpectedly, pO(2) in malignant ascites showed relatively high values (90.4 ± 27.72 mm Hg), which were mostly the same as those of arterial blood (97.09 ± 10.33 mm Hg, p = 0.858). Even in 19 patients whose samples were collected at bedside in room air, pO(2) of malignant ascites was 85.94 ± 23.94 mm Hg, which was patently higher than that in venous blood or in solid tumor tissues. CONCLUSION: Since the oxygen level critically affects the sensitivity of tumor cells to chemotherapeutic agents through metabolic transformation, the oxygenic condition in the peritoneal cavity may be beneficial for the progression of peritoneal metastasis, and also clinically important in considering the efficacy of chemotherapy. S. Karger AG 2010-10-01 /pmc/articles/PMC2988845/ /pubmed/21103196 http://dx.doi.org/10.1159/000321262 Text en Copyright © 2010 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published: October 2010
Emoto, Shigenobu
Kitayama, Joji
Yamaguchi, Hironori
Ishigami, Hironori
Kaisaki, Shoichi
Nagawa, Hirokazu
Analysis of pO(2) in Malignant Ascites of Patients with Peritoneal Dissemination of Gastric Cancer
title Analysis of pO(2) in Malignant Ascites of Patients with Peritoneal Dissemination of Gastric Cancer
title_full Analysis of pO(2) in Malignant Ascites of Patients with Peritoneal Dissemination of Gastric Cancer
title_fullStr Analysis of pO(2) in Malignant Ascites of Patients with Peritoneal Dissemination of Gastric Cancer
title_full_unstemmed Analysis of pO(2) in Malignant Ascites of Patients with Peritoneal Dissemination of Gastric Cancer
title_short Analysis of pO(2) in Malignant Ascites of Patients with Peritoneal Dissemination of Gastric Cancer
title_sort analysis of po(2) in malignant ascites of patients with peritoneal dissemination of gastric cancer
topic Published: October 2010
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2988845/
https://www.ncbi.nlm.nih.gov/pubmed/21103196
http://dx.doi.org/10.1159/000321262
work_keys_str_mv AT emotoshigenobu analysisofpo2inmalignantascitesofpatientswithperitonealdisseminationofgastriccancer
AT kitayamajoji analysisofpo2inmalignantascitesofpatientswithperitonealdisseminationofgastriccancer
AT yamaguchihironori analysisofpo2inmalignantascitesofpatientswithperitonealdisseminationofgastriccancer
AT ishigamihironori analysisofpo2inmalignantascitesofpatientswithperitonealdisseminationofgastriccancer
AT kaisakishoichi analysisofpo2inmalignantascitesofpatientswithperitonealdisseminationofgastriccancer
AT nagawahirokazu analysisofpo2inmalignantascitesofpatientswithperitonealdisseminationofgastriccancer